Key Principles and Recommended Regimens for First-line Antiretroviral Therapy
Summary
- Recent investigations have studied newer agents as part of NRTI-sparing regimens in treatment-naive patients
- The IAS-USA guidelines includes no NRTI-sparing as initial ART, but recognizes that they can produce comparable virological results as 3-drug regimens[IASUSA ART]
- The DHHS guidelines now include dolutegravir/lamivudine as a recommended regimen for most people with HIV, except for individuals with HIV-1 RNA > 500,000 copies/mL, potential HBV coinfection, or those with no HIV genotype resistance testing results for reverse transcriptase
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Initial Antiretroviral Therapy